Forte Biosciences, Inc.
Support and Resistance Levels
Past performance
News About FBRX
All events for FBRX
All deals for FBRX
Financial Ratios
Financial Statements
FBRX vs Sector & Peers
About Forte Biosciences, Inc.
Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas. Website fortebiorx.com
Headquarters Dallas, TX, US